Institution
American College of Rheumatology
Nonprofit•Atlanta, Georgia, United States•
About: American College of Rheumatology is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Guideline & Population. The organization has 141 authors who have published 117 publications receiving 33521 citations.
Topics: Guideline, Population, Vasculitis, Rheumatology, Health care
Papers published on a yearly basis
Papers
More filters
••
TL;DR: It is vital that all members of a pain center who are treating the client be provided information impacting the ability to communicate with the patient or a member of the team.
Abstract: From the point of view of a behavioral medicine professional, confidentiality was probably violated. From the view of a rehabilitation medicine professional, it was not. It is vital that all members of a pain center who are treating the client be provided information impacting the ability to communicate with the patient or a member of the team.
In this context, extending a …
1 citations
••
1 citations
••
1 citations
••
University of Alabama at Birmingham1, Toronto Western Hospital2, MetroHealth3, University of Texas Southwestern Medical Center4, Brigham and Women's Hospital5, Hospital for Special Surgery6, Cleveland Clinic7, Centers for Disease Control and Prevention8, Duke University9, American College of Rheumatology10, University of Nebraska Medical Center11
TL;DR: Mortezavi et al. as mentioned in this paper pointed out that patients receiving tofacitinib in Study A had a lower likelihood of a satisfactory response to pneumococcal vaccination (45.1%) compared to placebo-treated patients (68.4%), a difference of 23.3%, 95% CI -36.6 to -9.6%.
Abstract: We appreciate the letter by Mortezavi et. al. describing vaccine response and the frequency of disease worsening in patients receiving tofacitinib. The ACR COVID Vaccine Guidance Task Force was aware of the two studies cited and appreciate their summary of the results. We would point out that in the rheumatoid arthritis study by Winthrop et. al., patients receiving tofacitinib in Study A had a lower likelihood of a satisfactory response to pneumococcal vaccination (45.1%) compared to placebo-treated patients (68.4%), a difference of 23.3%, 95% CI -36.6 to -9.6%. The differences were numerically even larger for patients receiving concomitant tofacitinib and methotrexate (31.6% of patients with a satisfactory response, difference of -30.2%, 95% CI -47.3 to -11.4%) compared to methotrexate monotherapy.
1 citations
Authors
Showing all 142 results
Name | H-index | Papers | Citations |
---|---|---|---|
Anthony S. Fauci | 185 | 960 | 133535 |
David T. Felson | 153 | 861 | 133514 |
Peter Tugwell | 129 | 948 | 125480 |
Marc C. Hochberg | 127 | 691 | 87268 |
Frederick Wolfe | 119 | 417 | 101272 |
Daniel E. Furst | 109 | 643 | 59748 |
Daniel H. Solomon | 100 | 623 | 38921 |
Claire Bombardier | 100 | 295 | 61805 |
James F. Fries | 100 | 369 | 83589 |
Theodore Pincus | 97 | 420 | 46012 |
Elie A. Akl | 95 | 482 | 58031 |
Matthew H. Liang | 93 | 339 | 53685 |
Sherine E. Gabriel | 91 | 273 | 63492 |
Michael E. Weinblatt | 86 | 455 | 44442 |
Gene G. Hunder | 86 | 244 | 61920 |